SBC Medical Group Holdings Inc
For the period ended Jun 30, 2025. Filed Aug 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 13, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Rule 10b5-1 Trading Arrangements
On June 22, 2025, Yoshiyuki Aikawa, our Chief Executive Officer and Chairman, adopted a Rule 10b5-1 trading arrangement, which provides for the potential sale of up to 1,030,000 shares of the Company’s common stock. Dr. Aikawa’s 10b5-1 plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and unless otherwise terminated pursuant to its terms, provides for sales from September 22, 2025 to September 22, 2026 or an earlier date on which all shares thereunder are sold.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.